Emeis announced its early exit from the accelerated safeguard plan on February 20, 2026, following approval from the Nanterre Court of Economic Affairs. This exit comes after three years of restructuring the health services and support group.
Emeis Group, a French operator of psychiatric clinics, medical care and rehabilitation clinics, nursing homes, home care services, and service residences, secured its exit from the accelerated safeguard plan on February 20, 2026. This recovery procedure had been initiated previously to address financial difficulties. The group employs approximately 83,500 experts and professionals and welcomes around 280,000 residents, patients, and beneficiaries annually in about twenty countries.
Key Factors Enabling the Exit
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The exit was made possible by three main factors: the execution of a major divestment plan with 2.45 billion euros in divestments completed or secured since mid-2022; the strengthening of the balance sheet structure since December 18, 2025, with the raising of 3.15 billion euros in new financing allowing the early refinancing of A/B/C/D bank debt; and the improvement of operational performance since mid-2024 characterized by increased occupancy rates, higher operational margins, and now positive free cash flow. The group anticipates an average constant-scope EBITDAR growth of +12% to +16% between 2024 and 2028.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 1T2026
Key reported figures
Revenue: 1509M€
Risks mentioned
Les mesures de qualité engagées en 2024 et 2025 sont essentielles.
La demande de lits devrait dépasser l'offre de 550 000 d'ici 2030.
Opportunities identified
Croissance organique de +6,3 % au 1T2026, soutenue par des taux d'occupation améliorés.
Réduction de la sensibilité aux pressions inflationnistes grâce à un hedging sur 90 % des dépenses énergétiques.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
